Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.980
+0.020 (1.02%)
At close: Sep 29, 2026, 4:00 PM EDT
2.010
+0.030 (1.52%)
Pre-market: Sep 30, 2026, 4:00 AM EDT
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $85.04 million as of September 29, 2026. Its market cap has increased by 19.94% in one year.
Market Cap
85.04M
Enterprise Value
85.41M
1-Year Change
19.94%
Ranking
Category
Stock Price
$1.98
ChartMarket Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $85.04M, a decrease of -93.62%. That is a compound annual growth rate of -36.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 85.04M | -6.71% |
| Dec 31, 2025 | 91.16M | -66.00% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MaxCyte | 118.69M |
| Apyx Medical | 116.26M |
| electroCore | 97.82M |
| Hyperfine | 88.19M |
| Microbot Medical | 84.96M |
| LENSAR | 83.79M |
| Sera Prognostics | 80.48M |
| CVRx, Inc. | 69.00M |